EUVIMEDEUVIMED entdecken
Open Access

Non‐invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1 H magnetic resonance spectroscopy

In-Young Choi iD, Wen-Tung Wang, Bhumsoo Kim, Junguk Hur, David C Robbins, Dae-Gyu Jang, Masha G Savelieff iD, Eva L Feldman iD, Phil Lee iD

Journal of Neurochemistry · 2024

DOI: 10.1111/jnc.15996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von In-Young Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hoglund Biomedical Imaging Center, University of Kansas Medical Center (KUMC), Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, Sinai Medical Staff Foundation Research on Studying Diet and Brain Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) is a complex chronic metabolic disorder characterized by hyperglycemia because of insulin resistance. Diabetes with chronic hyperglycemia may alter brain metabolism, including brain glucose and neurotransmitter levels; however, detailed, longitudinal studies of metabolic alterations in T2D are lacking. To shed insight, here, we characterized the consequences of poorly controlled hyperglycemia on neurochemical profiles that reflect metabolic alterations of the brain in both humans and animal models of T2D. Using in vivo 1 H magnetic resonance spectroscopy, we quantified 12 metabolites cross‐sectionally in T2D patients and 20 metabolites longitudinally in T2D db / db mice versus db + controls. We found significantly elevated brain glucose (91%, p < 0.001), taurine (22%, p = 0.02), glucose+taurine (56%, p < 0.001), myo ‐inositol (12%, p = 0.02), and choline‐containing compounds (10%, p = 0.01) in T2D patients versus age‐ and sex‐matched controls, findings consistent with measures in T2D db / db versus control db + littermates. In mice, hippocampal and striatal neurochemical alterations in brain glucose, ascorbate, creatine, phosphocreatine, γ‐aminobutyric acid, glutamate, glutamine, glutathione, glycerophosphoryl‐choline, lactate, myo ‐inositol, and taurine persisted in db / db mice with chronic disease progression from 16 to 48 weeks of age, which were distinct from control db + mice. Overall, our study demonstrates the utility of 1 H magnetic resonance spectroscopy as a non‐invasive tool for characterizing and monitoring brain metabolic changes with T2D progression. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2BrainAnimalsHumansMaleMiceFemaleMiddle AgedProton Magnetic Resonance SpectroscopyMice, Inbred C57BLMagnetic Resonance SpectroscopyAgedGlucose

Stichwörter der Autor:innen

brain metabolismhuman brainmagnetic resonance spectroscopymouseneurochemical profiletype 2 diabetes

Substanzen

Glucose

Autor:innen und Institutionen

  • Hoglund Biomedical Imaging Center, University of Kansas Medical Center (KUMC), Kansas City, Kansas, USA.
  • Department of Neurology, KUMC, Kansas City, Kansas, USA.
  • Department of Radiology, KUMC, Kansas City, Kansas, USA.
  • Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
  • NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.

ORCID-Profile: In-Young Choi, Masha G Savelieff, Eva L Feldman, Phil Lee

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • Sinai Medical Staff Foundation Research on Studying Diet and Brain Health
  • Robert E. Nederlander Sr. Program for Alzheimer's Research
  • NeuroNetwork for Emerging Therapies
  • NCRR NIH HHS
  • Nathan and Rose Milstein Research Fund
  • Robert and Katherine Jacobs Environmental Health Initiative

Zitieren

APA

Choi, I. Y., Wang, W. T., Kim, B., Hur, J., Robbins, D. C., Jang, D. G., Savelieff, M. G., Feldman, E. L., & Lee, P. (2024). Non‐invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1 H magnetic resonance spectroscopy. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15996

Vancouver

Choi IY, Wang WT, Kim B, Hur J, Robbins DC, Jang DG, et al. Non‐invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1 H magnetic resonance spectroscopy. Journal of Neurochemistry. 2024. doi:10.1111/jnc.15996

BibTeX
@article{Choi2024,
  author = {Choi, In-Young and Wang, Wen-Tung and Kim, Bhumsoo and Hur, Junguk and Robbins, David C and Jang, Dae-Gyu and Savelieff, Masha G and Feldman, Eva L and Lee, Phil},
  title = {Non‐invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1 H magnetic resonance spectroscopy},
  journal = {Journal of Neurochemistry},
  year = {2024},
  doi = {10.1111/jnc.15996}
}
Kostenlos starten →